INTRODUCTION
I-cell disease and pseudo-Hurler polydystrophy are autosomal recessive lysosomal storage diseases with a Hurler syndromelike presentation. I-cell disease is clinically more severe, often noted shortly after birth, whereas pseudo-Hurler polydystrophy has a later onset and a slower course. Both diseases are characterized by decreased activities of many lysosomal enzymes in connective tissue cells and by markedly elevated enzyme levels in body fluids (1) . Cultured skin fibroblasts from these patients secrete acid hydrolases into the medium and cannot take up these enzymes; yet they maintain the ability to endocytose lysosomal enzymes from normal cells. Normal fibroblasts cannot take up I-cell-derived acid hydrolases. These observations led Hickman and Neufeld (2) to propose that the defect in I-cell disease and pseudo-Hurler polydystrophy is the lack of the recognition marker necessary for lysosomal enzyme targeting. It is now established that 6-phosphomannosyl residues on high mannose type oligosaccharide units serve as an essential component of this recognition marker (3) (4) (5) . Hasilik and Neufeld (6) have demonstrated that I-cell fibroblasts, in contrast to normal fibroblasts, fail to incorporate [32P] phosphate into newly synthesized 83- hexosaminidase, cathepsin D, and a-glucosidase. These observations and those by Bach et al. (7) support the hypothesis that the defect in I-cell disease and pseudo-Hurler polydystrophy is in the biosynthesis of the phosphomannosyl signal responsible for the targeting of newly synthesized acid hydrolases to lysosomes.
We have reported that biosynthetic intermediates of the acid hydrolase j8-glucuronidase contain phos-phate groups in diester linkage between mannose residues of the underlying oligosaccharide and outer a-linked N-acetylglucosamine residues (8) . A similar observation has been made by Hasilik et al. (9) . Because the phosphate is present in mature enzymes as a phosphomonoester moiety (4, 5) , we proposed that the phosphorylation of acid hydrolases occurs by transfer of a-N-acetylglucosamine 1-phosphate to mannose residues of high mannose type oligosaccharides followed by removal of the N-acetylglucosamine residues to expose 6-phosphomannosyl groups. This, in turn, would allow binding of the acid hydrolases to the specific receptors that mediate the transport of the enzymes to lysosomes (Fig. 1) (8) . We have recently developed assays for UDP-N-acetylglucosamine:glycoprotein N-acetylglucosaminylphosphotransferase (11) and a-N-acetylglucosaminyl phosphodiesterase (12) , the enzymes catalyzing the first two reactions in this sequence. We demonstrate that fibroblasts from patients with I-cell disease and pseudoHurler polydystrophy are severely deficient in Nacetylglucosaminylphosphotransferase activity, thus identifying the biochemical basis for these diseases.
METHODS
Materials. The sources of the materials are described in reference 11 . Bovine thyroglobulin was digested with Pronase as described (11) and the high mannose glycopeptide was isolated by affinity chromatography on concanavalin ASepharose (1 x 25 cm). The column was eluted with 170 ml of 20 mM Tris-Cl, pH 8.0/155 mM NaCl, 90 ml of the same buffer containing 10 mM a-methylglucoside, and 75 ml of the buffer containing 100 mM a-methyl mannoside at 60°C. The a-methyl mannoside fraction was subjected to gel filtration on Sephadex G-25 to separate the haptene from the glycopeptides which were then used as described below.
Cells after feeding (at least 1 wk after last passage). The cells were washed in 20 mM Tris-Cl, pH 7.45/155 mM NaCl. 2 vol of 50 mM Tris-Cl, pH 7.45, containing 0.75% (wt/vol) Triton X-100 were added to the cell pellet, and the cells were disrupted with 10 passes on a motor-driven Potter-Elvehjem homogenizer. Protein concentrations were determined by a modification ofthe method of Lowry et al. (13), including 0.5% sodium dodecyl sulfate.
Enzyme assays. UDP-N-acetylglucosamine:glycoprotein N-acetylglucosamine-1-phosphotransferase activity was determined exactly as described (11) except that the incubation time was 30 min, and the concanavalin A-Sepharose was extruded into a scintillation vial and counted after the addition of 1 ml H20 and 10 ml scintillation fluid. a-N-Acetylglucosaminyl phosphodiesterase was measured as described (12) except that the reaction mixtures contained 50 mM Tris-Cl, pH 7.45, 0.5% Triton X-100, 5 mM EDTA, and 10 mM N-acetylmannosamine. The EDTA and N-acetylmannosamine inhibit lysosomal a-N-acetylglucosaminidase (12) . One unit of activity is defined as the amount of enzyme catalyzing the cleavage of 1% of the covering N-acetylglucosamine from the substrate in 1 h. ,8-Galactosidase reaction mixtures contained 2.5 mM p-nitrophenol-,f-D-galactoside, 0.1 M Na acetate, pH 4.6, 1% (wt/vol) Triton X-100, and cell homogenate protein (10-250 jAg) in a final volume of 0.05 ml. Reactions were stopped after 3 h by the addition of 0.05 ml of ice-cold 20% (wt/vol) trichloroacetic acid, incubated five min on ice, and centrifuged at 12,000 g for five min. A 0.075-ml aliquot of the supernate was added to 0.3 ml of 0.5 M Na2CO3, and the A41o was measured. One unit is defined as 1 nmol p-nitrophenol liberated per h, using a molar extinction coefficient of 18,600 liters/mol per cm for p-nitrophenol.
RESULTS
Normal human diploid fibroblasts have N-acetylglucosaminylphosphotransferase. Fig. 2 Mild acid treatment (pH 2, 1000C, 30 min) of the endof3-N-acetylglucosaminidase H released material released 92% of the 3H as free N-acetylglucosamine while the 32P remained with the oligosaccharide which now bound more tightly to the QAE-Sephadex. This behavior is expected when a phosphodiester moiety is converted to a phosphomonoester; (d) strong acid hydrolysis (1 N HC1, 100°C, 4 h) of the product quantitatively yielded a 32P-labeled compound which comigrated with mannose 6-phosphate on paper chromatography and which was totally converted to 6-phosphogluconate by a mixture of phosphomannose isomerase, phosphoglucose isomerase, and glucose 6-phosphate dehydrogenase.
These data, taken together, prove that the assay is measuring the transfer ofN-acetylglucosamine 1-phosphate from UDP-N-acetylglucosamine to the 6-hydroxyl ofmannose residues ofhigh mannose-type oligosaccharides of endogenous glycoproteins.
N-acetylglucosaminylphosphotransferase activity in I-cell and pseudo-Hurler fibroblasts. Because fibroblasts from patients with I-cell disease synthesize lysosomal enzymes that are deficient in phosphate content (6, 7), we assayed fibroblasts from these patients and from patients with pseudo-Hurler polydystrophy for N-acetylglucosaminylphosphotransferase activity. The results of these assays are shown in Fig. 2 and Table I Mixing experiments between normal homogenates and nine of the I-cell or pseudo-Hurler homogenates that were devoid of activity demonstrated the activity expected of appropriately diluted normal homogenate. This suggests that the presence of an inhibitor or the lack of an activator is not the basis for the enzyme deficiency in the abnormal fibroblasts. Similarly, mixing of the GM1494 homogenate with homogenates from nine ofthe other abnormal fibroblast lines yielded only the activity expected of the GM 1494 line. No activity was seen in 12 other mixing experiments between affected fibroblasts.
In our previous study we establish that the high mannose-type glycopeptide of thyroglobulin can act as an exogenous acceptor for the N-acetylglucosaminylphosphotransferase (11) . Therefore this acceptor was tested with the fibroblast extracts to exclude the possibility that the defect in the abnormal cell lines was in the endogenous acceptor rather than in the Nacetylglucosaminylphosphotransferase. As shown in Table II a-N-acetylglucosaminyl phosphodiesterase assays. We reported that fibroblasts from a single patient with I-cell disease have normal levels of a-N-acetylglucosaminyl phosphodiesterase activity (12) . To extend this observation we measured this enzyme activity in the I-cell disease and pseudo-Hurler polydystrophy fibroblast cultures. As shown in Table I , the enzyme activity was normal or elevated in all of the affected fibroblasts.
,3-Galactosidase assays. All of the abnormal fibroblasts were deficient in the acid hydrolase 3-galactosidase (Table I ). The levels were more severely depressed in the I-cell fibroblasts than in pseudo-Hurler polydystrophy fibroblasts. This result is consistent with a previous report (15) Clinically, pseudo-Hurler polydystrophy is less severe than I-cell disease. The most probable biochemical explanation for this observation is that pseudo-Hurler patients have slightly higher levels of N-acetylglucosaminylphosphotransferase activity than do I-cell patients. This finding is suggested by the data in Table I , but a larger series and/or a more sensitive assay is needed to confirm this hypothesis.
Note added in proof. After this paper was accepted for publication, Hasilik et al. reported that two patients with Icell disease are deficient in UDP-N-acetylglucosamine: lysosomal enzyme N-acetylglucosamine 1-phosphate transferase (1981. Biochem. Biophys Res. Commuin. 98: 761-767).
